Finance

Lists
MDLN:NASDAQ
Medline Inc
US$39.10
-0.92%
(-0.37) 1D
ኖቬም 16, 11:35:34 ጥዋት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDLN...
Open
US$38.28
High
US$39.62
Low
US$38.28
Mkt. cap
51.44 ቢ
Avg. vol.
9.55 ሚ
Volume
1.96 ሚ
P/E ratio
65.89
52-wk high
US$50.88
52-wk low
US$31.37
EPS
US$0.59
Shares outstanding
878.66 ሚ
No. of employees
45 ሺ
Open
US$38.28
High
US$39.62
Low
US$38.28
Mkt. cap
51.44 ቢ
Avg. vol.
9.55 ሚ
Volume
1.96 ሚ
P/E ratio
65.89
52-wk high
US$50.88
52-wk low
US$31.37
EPS
US$0.59
Shares outstanding
878.66 ሚ
No. of employees
45 ሺ
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
ከ3 ሰዓቶች በፊት
Medline Shareholders Launch Secondary Offering of 60 Million Shares
Investing.com
Investing.com
·
ከ4 ሰዓቶች በፊት
Medline shareholders launch 60 million share offering
Yahoo Finance Singapore
Yahoo Finance Singapore
·
ከ4 ሰዓቶች በፊት
Medline Inc. announces launch of secondary offering of Class A common stock
About Medline Inc
CEO-
Employees45 ሺ
Founded1966
Headquarters-
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 17 analysts giving stock ratings to MDLN in the past 3 months
Strong buy
Buy
17
Hold
0
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for MDLN in the last 3 months.
Highest
Current US$39.10
US$55.00 (+40.65%)
Average
US$47.50 (+21.47%)
Lowest
US$43.00 (+9.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ivan Feinseth
Tigress Financial
Buy
Reiterated
US$55.00
+40.6%
11/13/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
US$47.00
+20.2%
11/12/2026
Ryan Halsted
RBC Capital
Buy
Reiterated
US$46.00
+17.6%
11/11/2026
Andrew Obin
Bank of America Securities
Buy
Maintained
-
-
11/09/2026
Michael Cherny
Leerink Partners
Buy
Reiterated
US$46.00
+17.6%
11/05/2026
Kevin Caliendo
UBS
Buy
Reiterated
US$49.00
+25.3%
11/05/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
US$48.00
+22.7%
11/05/2026
Sean Dodge
BMO Capital
Buy
Maintained
US$47.00
+20.2%
11/05/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
US$44.00
+12.5%
11/05/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
US$44.00
+12.5%
11/05/2026
Lee Hambright
Bernstein
Buy
Maintained
US$49.00
+25.3%
11/05/2026
Patrick B Donnelly
Citi
Buy
Maintained
US$47.00
+20.2%
11/05/2026
Glen Santangelo
Barclays
Buy
Maintained
US$43.00
+10%
11/04/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
US$45.00
+15.1%
10/22/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
09/23/2026
Jailendra Singh
Truist Financial
Buy
Maintained
-
-
09/22/2026
David Larsen
BTIG
Buy
Maintained
US$55.00
+40.6%
08/27/2026
Stephen Baxter
Wells Fargo
Hold
Reiterated
US$34.00
-13.1%
08/11/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
US$45.00
+15.1%
08/10/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
US$45.00
+15.1%
08/06/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
US$37.00
-5.4%
08/06/2026
Daniel Grosslight
Citi
Buy
Maintained
US$45.00
+15.1%
08/05/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$53.00
+35.5%
05/07/2026
David Roman
Goldman Sachs
Buy
Maintained
US$50.00
+27.9%
05/06/2026
Jason Bednar
Piper Sandler
Buy
Maintained
US$55.00
+40.6%
05/04/2026
Patrick Wood
Morgan Stanley
Buy
Maintained
US$48.00
+22.7%
02/25/2026
Last report
4 ኖቬም 2026
Fiscal period
Q3 2026
US$0.44 / US$0.35
+26.67%beat
Revenue / Est. (USD)
7.86 ቢ / 7.73 ቢ
+1.66%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
7.79 ቢ
7.35 ቢ
7.68 ቢ
7.86 ቢ
Cost of goods sold
5.87 ቢ
5.51 ቢ
5.80 ቢ
6.00 ቢ
Cost of revenue
5.87 ቢ
5.51 ቢ
5.80 ቢ
6.00 ቢ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.26 ቢ
1.23 ቢ
1.30 ቢ
1.26 ቢ
Operating expense
1.47 ቢ
1.42 ቢ
1.48 ቢ
1.44 ቢ
Total operating expenses
7.34 ቢ
6.93 ቢ
7.29 ቢ
7.45 ቢ
Operating income
443.00 ሚ
422.00 ሚ
399.00 ሚ
410.00 ሚ
Other non operating income
-6.00 ሚ
1.00 ሚ
-42.00 ሚ
-1.00 ሚ
EBT including unusual items
206.00 ሚ
291.00 ሚ
235.00 ሚ
386.00 ሚ
EBT excluding unusual items
276.00 ሚ
291.00 ሚ
239.00 ሚ
296.00 ሚ
Income tax expense
26.00 ሚ
52.00 ሚ
96.00 ሚ
68.00 ሚ
Effective tax rate
12.62%
17.87%
40.85%
17.62%
Other operating expenses
30.00 ሚ
15.00 ሚ
12.00 ሚ
10.00 ሚ
Net income
182.00 ሚ
129.00 ሚ
60.00 ሚ
195.00 ሚ
Net profit margin
2.34%
1.75%
0.78%
2.48%
Earnings per share
0.31
0.33
0.50
0.44
Interest and investment income
34.00 ሚ
29.00 ሚ
49.00 ሚ
47.00 ሚ
Interest expense
-200.00 ሚ
-165.00 ሚ
-168.00 ሚ
-165.00 ሚ
Net interest expenses
-166.00 ሚ
-136.00 ሚ
-119.00 ሚ
-118.00 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
704.00 ሚ
676.00 ሚ
655.00 ሚ
669.00 ሚ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች